Related Experiment Video
Updated: Jul 18, 2026
09:15
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Targeting triglycerides as prognostic indicators and determining lowest values for patient benefit.
1Preventive Cardiology, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA. sprechd@ccf.org
Current Cardiology Reports
|August 16, 2001
Summary
Serum triglyceride levels are important for vascular disease prediction. Recent analyses confirm triglycerides
Area of Science:
- Cardiovascular Medicine
- Metabolic Disorders
- Lipid Metabolism
Background:
- Serum triglyceride (TG) levels are linked to vascular disease onset.
- Correlations with diabetes, BMI, and HDL-C can obscure TG's independent contribution.
- Advanced analytical methods increasingly highlight TG's independent role.
Purpose of the Study:
- To clarify the independent role of triglycerides in cardiovascular disease.
- To examine the relationship between TG reduction and clinical outcomes.
- To assess the impact of accounting for correlated lipid parameters.
Main Methods:
- Review of existing literature and pharmacologic trial data.
- Analysis of TG-correlated measurements including intermediate particles, LDL density, and HDL-C.
- Examination of national cholesterol treatment guidelines.
Main Results:
- Triglycerides are independently relevant to cardiovascular disease onset.
- TG reduction often parallels improved outcomes, though direct correlation is complex.
- Accounting for TG-correlated factors improves outcome relationships.
- National guidelines now use TG levels to target non-HDL-C therapy.
Conclusions:
- Triglycerides are significant independent predictors of cardiovascular disease.
- Therapeutic strategies targeting TG and related lipoproteins are crucial.
- Further research into the complex interplay of lipid parameters is warranted.
Related Concept Videos
01:13Therapeutic Index
The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:25Blood Studies for Cardiovascular System III: Serum Lipid Profile
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...